<?xml version="1.0" encoding="UTF-8"?>
<!-- generator="wordpress/2.2" -->
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	>

<channel>
	<title>Vioxx Information and News</title>
	<link>http://vioxx-attorney.letsgetinteractive.com</link>
	<description>Vioxx Attoney Information</description>
	<pubDate>Wed, 23 Jul 2008 02:11:00 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.2</generator>
	<language>en</language>
			<item>
		<title>Ministers back compensation campaign over arthritis drug Vioxx - Daily Telegraph</title>
		<link>http://vioxx-attorney.letsgetinteractive.com/2008/07/22/ministers-back-compensation-campaign-over-arthritis-drug-vioxx-daily-telegraph/</link>
		<comments>http://vioxx-attorney.letsgetinteractive.com/2008/07/22/ministers-back-compensation-campaign-over-arthritis-drug-vioxx-daily-telegraph/#comments</comments>
		<pubDate>Wed, 23 Jul 2008 02:11:00 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[Vioxx News and Information]]></category>

		<guid isPermaLink="false">http://vioxx-attorney.letsgetinteractive.com/2008/07/22/ministers-back-compensation-campaign-over-arthritis-drug-vioxx-daily-telegraph/</guid>
		<description><![CDATA[More than Â£2 billion has been paid out to 44,000 Americans who took victims of the painkiller, called Vioxx, which was taken off the market in 2004. But the makers of the drug, Merck, have not paid anything in this country. Merck stressed that it &#8230;
Originally Syndicated via RSS from vioxx - Live Search News
]]></description>
			<content:encoded><![CDATA[<p>More than Â£2 billion has been paid out to 44,000 Americans who took victims of the painkiller, called Vioxx, which was taken off the market in 2004. But the makers of the drug, Merck, have not paid anything in this country. Merck stressed that it &#8230;
<p>Originally Syndicated via RSS from <a href="http://www.telegraph.co.uk/news/uknews/2446165/Ministers-back-compensation-campaign-over-arthritis-drug-Vioxx.html">vioxx - Live Search News</a></p>
]]></content:encoded>
			<wfw:commentRss>http://vioxx-attorney.letsgetinteractive.com/2008/07/22/ministers-back-compensation-campaign-over-arthritis-drug-vioxx-daily-telegraph/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Merck&#8217;s magic act loses dazzle - Reuters</title>
		<link>http://vioxx-attorney.letsgetinteractive.com/2008/07/22/mercks-magic-act-loses-dazzle-reuters/</link>
		<comments>http://vioxx-attorney.letsgetinteractive.com/2008/07/22/mercks-magic-act-loses-dazzle-reuters/#comments</comments>
		<pubDate>Tue, 22 Jul 2008 19:38:00 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[Vioxx News and Information]]></category>

		<guid isPermaLink="false">http://vioxx-attorney.letsgetinteractive.com/2008/07/22/mercks-magic-act-loses-dazzle-reuters/</guid>
		<description><![CDATA[NEW YORK (Reuters) - The glory is quickly fading for drugmaker Merck &#038; Co, which dazzled investors over the past three years by recovering from a crisis over its Vioxx painkiller and rolling out blockbuster products. For now the stock is looking more &#8230;
Originally Syndicated via RSS from vioxx - Live Search News
]]></description>
			<content:encoded><![CDATA[<p>NEW YORK (Reuters) - The glory is quickly fading for drugmaker Merck &#038; Co, which dazzled investors over the past three years by recovering from a crisis over its Vioxx painkiller and rolling out blockbuster products. For now the stock is looking more &#8230;
<p>Originally Syndicated via RSS from <a href="http://www.reuters.com/article/newsOne/idUSN2228961320080722">vioxx - Live Search News</a></p>
]]></content:encoded>
			<wfw:commentRss>http://vioxx-attorney.letsgetinteractive.com/2008/07/22/mercks-magic-act-loses-dazzle-reuters/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Merck &#038; Company Incorporated - Morning Call</title>
		<link>http://vioxx-attorney.letsgetinteractive.com/2008/07/22/merck-company-incorporated-morning-call/</link>
		<comments>http://vioxx-attorney.letsgetinteractive.com/2008/07/22/merck-company-incorporated-morning-call/#comments</comments>
		<pubDate>Tue, 22 Jul 2008 08:25:00 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[Vioxx News and Information]]></category>

		<guid isPermaLink="false">http://vioxx-attorney.letsgetinteractive.com/2008/07/22/merck-company-incorporated-morning-call/</guid>
		<description><![CDATA[In the latest disappointment for the cholesterol pill Vytorin, a major European study in patients with heart valve disease found the drug didn&#8217;t prevent worsening of the disease or lower the need for valve surgery. Results of a preliminary analysis &#8230;
Originally Syndicated via RSS from vioxx - Live Search News
]]></description>
			<content:encoded><![CDATA[<p>In the latest disappointment for the cholesterol pill Vytorin, a major European study in patients with heart valve disease found the drug didn&#8217;t prevent worsening of the disease or lower the need for valve surgery. Results of a preliminary analysis &#8230;
<p>Originally Syndicated via RSS from <a href="http://www.mcall.com/topic/economy-business-finance/merck-%26-company-incorporated-ORCRP009787.topic">vioxx - Live Search News</a></p>
]]></content:encoded>
			<wfw:commentRss>http://vioxx-attorney.letsgetinteractive.com/2008/07/22/merck-company-incorporated-morning-call/feed/</wfw:commentRss>
		</item>
		<item>
		<title>U.S. firms&#8217; attraction abroad is growing - San Francisco Gate</title>
		<link>http://vioxx-attorney.letsgetinteractive.com/2008/07/21/us-firms-attraction-abroad-is-growing-san-francisco-gate/</link>
		<comments>http://vioxx-attorney.letsgetinteractive.com/2008/07/21/us-firms-attraction-abroad-is-growing-san-francisco-gate/#comments</comments>
		<pubDate>Tue, 22 Jul 2008 02:41:00 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[Vioxx News and Information]]></category>

		<guid isPermaLink="false">http://vioxx-attorney.letsgetinteractive.com/2008/07/21/us-firms-attraction-abroad-is-growing-san-francisco-gate/</guid>
		<description><![CDATA[January February March April May June July August September October November December 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 Foreign tourists aren&#8217;t the only ones who see the United States as a great value right now &#8230;
Originally Syndicated via RSS from vioxx - Live Search News
]]></description>
			<content:encoded><![CDATA[<p>January February March April May June July August September October November December 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 Foreign tourists aren&#8217;t the only ones who see the United States as a great value right now &#8230;
<p>Originally Syndicated via RSS from <a href="http://www.sfgate.com/cgi-bin/article.cgi?f=/c/a/2008/07/22/BUD911SLOM.DTL">vioxx - Live Search News</a></p>
]]></content:encoded>
			<wfw:commentRss>http://vioxx-attorney.letsgetinteractive.com/2008/07/21/us-firms-attraction-abroad-is-growing-san-francisco-gate/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Vioxx report hits at Merck (Financial Times)</title>
		<link>http://vioxx-attorney.letsgetinteractive.com/2008/07/21/vioxx-report-hits-at-merck-financial-times/</link>
		<comments>http://vioxx-attorney.letsgetinteractive.com/2008/07/21/vioxx-report-hits-at-merck-financial-times/#comments</comments>
		<pubDate>Mon, 21 Jul 2008 19:41:50 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[Vioxx News and Information]]></category>

		<guid isPermaLink="false">http://vioxx-attorney.letsgetinteractive.com/2008/07/21/vioxx-report-hits-at-merck-financial-times/</guid>
		<description><![CDATA[Merck , the US pharmaceuticals group, played down the risks of taking its painkiller Vioxx in reports in academic journals and early submissions to regulators, according to a study to be published on Wednesday.
Originally Syndicated via RSS from Yahoo! News Search Results for vioxx
]]></description>
			<content:encoded><![CDATA[<p>Merck , the US pharmaceuticals group, played down the risks of taking its painkiller Vioxx in reports in academic journals and early submissions to regulators, according to a study to be published on Wednesday.
<p>Originally Syndicated via RSS from <a href="http://us.rd.yahoo.com/dailynews/rss/search/vioxx/SIG=127m5iatd/*http%3A//www.ft.com/cms/s/0/1df6f674-0b19-11dd-8ccf-0000779fd2ac.html">Yahoo! News Search Results for vioxx</a></p>
]]></content:encoded>
			<wfw:commentRss>http://vioxx-attorney.letsgetinteractive.com/2008/07/21/vioxx-report-hits-at-merck-financial-times/feed/</wfw:commentRss>
		</item>
		<item>
		<title>UPDATE: Merck 2Q Profit Gain Overshadowed By New Worries - CNN Money</title>
		<link>http://vioxx-attorney.letsgetinteractive.com/2008/07/21/update-merck-2q-profit-gain-overshadowed-by-new-worries-cnn-money/</link>
		<comments>http://vioxx-attorney.letsgetinteractive.com/2008/07/21/update-merck-2q-profit-gain-overshadowed-by-new-worries-cnn-money/#comments</comments>
		<pubDate>Mon, 21 Jul 2008 18:49:00 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[Vioxx News and Information]]></category>

		<guid isPermaLink="false">http://vioxx-attorney.letsgetinteractive.com/2008/07/21/update-merck-2q-profit-gain-overshadowed-by-new-worries-cnn-money/</guid>
		<description><![CDATA[Merck &#038; Co.&#8217;s (MRK) report of improved second-quarter earnings was overshadowed Monday by a new study raising questions about its cholesterol drugs, while the quarterly numbers confirmed fears of a slowdown in sales of cervical-cancer vaccine &#8230;
Originally Syndicated via RSS from vioxx - Live Search News
]]></description>
			<content:encoded><![CDATA[<p>Merck &#038; Co.&#8217;s (MRK) report of improved second-quarter earnings was overshadowed Monday by a new study raising questions about its cholesterol drugs, while the quarterly numbers confirmed fears of a slowdown in sales of cervical-cancer vaccine &#8230;
<p>Originally Syndicated via RSS from <a href="http://money.cnn.com/news/newsfeeds/articles/djf500/200807211854DOWJONESDJONLINE000540_FORTUNE5.htm">vioxx - Live Search News</a></p>
]]></content:encoded>
			<wfw:commentRss>http://vioxx-attorney.letsgetinteractive.com/2008/07/21/update-merck-2q-profit-gain-overshadowed-by-new-worries-cnn-money/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Merck Keeps Dropping Late After Pulling Outlook - Smart Money</title>
		<link>http://vioxx-attorney.letsgetinteractive.com/2008/07/21/merck-keeps-dropping-late-after-pulling-outlook-smart-money/</link>
		<comments>http://vioxx-attorney.letsgetinteractive.com/2008/07/21/merck-keeps-dropping-late-after-pulling-outlook-smart-money/#comments</comments>
		<pubDate>Mon, 21 Jul 2008 18:20:00 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[Vioxx News and Information]]></category>

		<guid isPermaLink="false">http://vioxx-attorney.letsgetinteractive.com/2008/07/21/merck-keeps-dropping-late-after-pulling-outlook-smart-money/</guid>
		<description><![CDATA[NEW YORK (Dow Jones) &#8212; Merck (MRK) posted a 5% increase in second-quarter net income, as the company pulled its 2008 and long-term guidance because of study results released earlier Monday that show Vytorin failed to show a benefit in people with a &#8230;
Originally Syndicated via RSS from vioxx - Live Search News
]]></description>
			<content:encoded><![CDATA[<p>NEW YORK (Dow Jones) &#8212; Merck (MRK) posted a 5% increase in second-quarter net income, as the company pulled its 2008 and long-term guidance because of study results released earlier Monday that show Vytorin failed to show a benefit in people with a &#8230;
<p>Originally Syndicated via RSS from <a href="http://www.smartmoney.com/bn/index.cfm?story=20080721060015&#038;cid=1108&#038;">vioxx - Live Search News</a></p>
]]></content:encoded>
			<wfw:commentRss>http://vioxx-attorney.letsgetinteractive.com/2008/07/21/merck-keeps-dropping-late-after-pulling-outlook-smart-money/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Merck 2Q Net Up 5%, Pulls Guidance On Vytorin Study - CNN Money</title>
		<link>http://vioxx-attorney.letsgetinteractive.com/2008/07/21/merck-2q-net-up-5-pulls-guidance-on-vytorin-study-cnn-money/</link>
		<comments>http://vioxx-attorney.letsgetinteractive.com/2008/07/21/merck-2q-net-up-5-pulls-guidance-on-vytorin-study-cnn-money/#comments</comments>
		<pubDate>Mon, 21 Jul 2008 17:16:00 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[Vioxx News and Information]]></category>

		<guid isPermaLink="false">http://vioxx-attorney.letsgetinteractive.com/2008/07/21/merck-2q-net-up-5-pulls-guidance-on-vytorin-study-cnn-money/</guid>
		<description><![CDATA[Merck &#038; Co. (MRK) posted a 5% increase in second-quarter net income, as the company pulled its 2008 and long-term guidance because of study results released earlier Monday that show Vytorin failed to show a benefit in people with a heart-valve &#8230;
Originally Syndicated via RSS from vioxx - Live Search News
]]></description>
			<content:encoded><![CDATA[<p>Merck &#038; Co. (MRK) posted a 5% increase in second-quarter net income, as the company pulled its 2008 and long-term guidance because of study results released earlier Monday that show Vytorin failed to show a benefit in people with a heart-valve &#8230;
<p>Originally Syndicated via RSS from <a href="http://money.cnn.com/news/newsfeeds/articles/djf500/200807211712DOWJONESDJONLINE000505_FORTUNE5.htm">vioxx - Live Search News</a></p>
]]></content:encoded>
			<wfw:commentRss>http://vioxx-attorney.letsgetinteractive.com/2008/07/21/merck-2q-net-up-5-pulls-guidance-on-vytorin-study-cnn-money/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Merck Reports Second-Quarter 2008 Financial Results - MSN MoneyCentral</title>
		<link>http://vioxx-attorney.letsgetinteractive.com/2008/07/21/merck-reports-second-quarter-2008-financial-results-msn-moneycentral/</link>
		<comments>http://vioxx-attorney.letsgetinteractive.com/2008/07/21/merck-reports-second-quarter-2008-financial-results-msn-moneycentral/#comments</comments>
		<pubDate>Mon, 21 Jul 2008 16:33:00 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[Vioxx News and Information]]></category>

		<guid isPermaLink="false">http://vioxx-attorney.letsgetinteractive.com/2008/07/21/merck-reports-second-quarter-2008-financial-results-msn-moneycentral/</guid>
		<description><![CDATA[Merck &#038; Co., Inc. today announced financial results for the second quarter of 2008. Merck reported non-GAAP (generally accepted accounting principles) earnings per share (EPS) of $0.86 for the second quarter of 2008, excluding restructuring charges &#8230;
Originally Syndicated via RSS from vioxx - Live Search News
]]></description>
			<content:encoded><![CDATA[<p>Merck &#038; Co., Inc. today announced financial results for the second quarter of 2008. Merck reported non-GAAP (generally accepted accounting principles) earnings per share (EPS) of $0.86 for the second quarter of 2008, excluding restructuring charges &#8230;
<p>Originally Syndicated via RSS from <a href="http://news.moneycentral.msn.com/provider/providerarticle.aspx?feed=BW&#038;date=20080721&#038;id=8917990">vioxx - Live Search News</a></p>
]]></content:encoded>
			<wfw:commentRss>http://vioxx-attorney.letsgetinteractive.com/2008/07/21/merck-reports-second-quarter-2008-financial-results-msn-moneycentral/feed/</wfw:commentRss>
		</item>
		<item>
		<title>HPC Vaccine Inspires Yellow Health Journalism - Seekingalpha.com</title>
		<link>http://vioxx-attorney.letsgetinteractive.com/2008/07/21/hpc-vaccine-inspires-yellow-health-journalism-seekingalphacom/</link>
		<comments>http://vioxx-attorney.letsgetinteractive.com/2008/07/21/hpc-vaccine-inspires-yellow-health-journalism-seekingalphacom/#comments</comments>
		<pubDate>Mon, 21 Jul 2008 15:21:00 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[Vioxx News and Information]]></category>

		<guid isPermaLink="false">http://vioxx-attorney.letsgetinteractive.com/2008/07/21/hpc-vaccine-inspires-yellow-health-journalism-seekingalphacom/</guid>
		<description><![CDATA[As the son of a doctor and the husband of another, I&#8217;m always on the lookout for irresponsible health journalism. And, boy, did I find some this weekend. Yesterday&#8217;s New York Post featured an &#8220;EXCLUSIVE&#8221; headlined &#8220;My girl died as &#8216;guinea pig&#8217; for &#8230;
Originally Syndicated via RSS from vioxx - Live Search News
]]></description>
			<content:encoded><![CDATA[<p>As the son of a doctor and the husband of another, I&#8217;m always on the lookout for irresponsible health journalism. And, boy, did I find some this weekend. Yesterday&#8217;s New York Post featured an &#8220;EXCLUSIVE&#8221; headlined &#8220;My girl died as &#8216;guinea pig&#8217; for &#8230;
<p>Originally Syndicated via RSS from <a href="http://seekingalpha.com/article/86036-hpc-vaccine-inspires-yellow-health-journalism">vioxx - Live Search News</a></p>
]]></content:encoded>
			<wfw:commentRss>http://vioxx-attorney.letsgetinteractive.com/2008/07/21/hpc-vaccine-inspires-yellow-health-journalism-seekingalphacom/feed/</wfw:commentRss>
		</item>
	</channel>
</rss>
